Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Mu, Ping Yale University United States Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation 5R01CA292949-03 Indu Kohaar, Ph.D., M.Phil., M.Sc. Nabavi, Sheida University Of Connecticut Storrs United States SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening 5R01CA297855-02 Claire Zhu, Ph.D. Nappi, Lucia Provincial Health Services Authority United States Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 5R37CA264798-03 Guillermo Marquez, Ph.D. Nath, Kavindra University Of Pennsylvania United States Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition 5R01CA228457-05 Nicholas Hodges, Ph.D. Neslund-Dudas, Christine Marie Henry Ford Health + Michigan State University Health Sciences United States HFH-MSU CSRN ACCrual Enrollment and Screening Site 5UG1CA287007-03 Elyse LeeVan, M.D., M.P.H. Oberg, Ann Laura Mayo Clinic Rochester United States Management and Data Coordination Unit for PCDC 5U24CA274496-04 Guillermo Marquez, Ph.D. Oskeritzian, Carole A University Of South Carolina At Columbia United States Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity 5R21CA274021-02 Guillermo Marquez, Ph.D. Ostrin, Edwin Justin University Of Tx Md Anderson Can Ctr United States Validation of blood-based biomarkers for risk assessment of lung cancer among individuals with no smoking history in the PLCO Cohort 1U01CA295902-01A1 Claire Zhu, Ph.D. Papadopoulos, Nickolas Johns Hopkins University United States Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids 5U01CA230691-08 Nicholas Hodges, Ph.D. Paulovich, Amanda G Fred Hutchinson Cancer Center United States Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment 5U2CCA271873-03 Sidney Fu, M.D. Paulson, Thomas G Fred Hutchinson Cancer Center United States The microbiome ecosystem of Barrett's esophagus and progression to cancer 5R21CA259687-02 Matthew Young, Ph.D. Permuth, Jennifer B H. Lee Moffitt Cancer Ctr & Res Inst United States Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology 5R37CA229810-07 Matthew Young, Ph.D. Pitteri, Sharon Stanford University United States Glycosylation and Immune Evasion in Urologic Tumors 5U01CA226051-05 Pozdeyev, Nikita University Of Colorado Denver United States Genetic architecture of thyroid cancer and its clinical utility 5R21CA282380-02 Wendy Wang, Ph.D., M.Sc. Punnen, Sanoj University Of Miami School Of Medicine United States The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection 5R01CA272766-03 Matthew Young, Ph.D. Pagination « First First page ‹ Previous Previous page … 9 10 11 12 … Next › Next page Last » Last page